Pneumothorax historical perspective: Difference between revisions

Jump to navigation Jump to search
m (Categories)
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}


== Overview ==


==Historical Perspective==
==Historical Perspective==
Line 9: Line 8:


Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' .
Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' .
==Overview==
==Historical Perspective==
===Discovery===
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
==Outbreaks==
*There have been several outbreaks of [disease name], which are summarized below:
==Landmark Events in the Development of Treatment Strategies==
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
==Impact on Cultural History==
==Famous Cases==
*The following are a few famous cases of [[disease name]]:
ategory: (name of the system)]]


== References ==
== References ==

Revision as of 17:10, 4 February 2018

Pneumothorax Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumothorax from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography/Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumothorax historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumothorax historical perspective

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumothorax historical perspective

CDC on Pneumothorax historical perspective

Pneumothorax historical perspective in the news

Blogs on Pneumothorax historical perspective

Directions to Hospitals Treating Pneumothorax

Risk calculators and risk factors for Pneumothorax historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Historical Perspective

Jean Marc Gaspard Itard, a student of Rene Laennec, first recognised pneumothorax in 1803, and Laennec himself described the full clinical picture in 1819[1].

Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' .


Overview

Historical Perspective

Discovery

  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Outbreaks

  • There have been several outbreaks of [disease name], which are summarized below:

Landmark Events in the Development of Treatment Strategies

  • In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Impact on Cultural History

Famous Cases

ategory: (name of the system)]]

References

  1. Laennec RTH. Traite de l'auscultation mediate et des maladies des poumons et du coeur. Part II. Paris, 1819.

Template:WH

Template:WS